An Improved Benefit-Risk Profile of Duvelisib in Patients...

An Improved Benefit-Risk Profile of Duvelisib in Patients with Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Who Received ≥2 Prior Therapies

Davids, Matthew, Hillmen, Peter, Montillo, Marco, Delgado, Julio, Kuss, Bryone, Tam, Constantine, Jäger, Ulrich, Ghia, Paolo, Stilgenbauer, Stephan, Cymbalista, Florence, Lustgarten, Stephanie, Weaver
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
19
Language:
english
Journal:
Clinical Lymphoma Myeloma and Leukemia
DOI:
10.1016/j.clml.2019.07.209
Date:
September, 2019
File:
PDF, 70 KB
english, 2019
Conversion to is in progress
Conversion to is failed